ALLISON BOOTIN: Open Payments
NPI 1689296402 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,837 in 115 payments from 17 companies in 2025. Trend: 2023 $4,114 · 2024 $4,694 · 2025 $2,837
Food & beverage: $2,710Education: $100Travel & lodging: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $1,218 |
| Arcutis Biotherapeutics, Inc. | 18 | $336 |
| GENZYME CORPORATION | 7 | $231 |
| Galderma Laboratories, L.P. | 8 | $219 |
| Lilly USA, LLC | 4 | $176 |
| Janssen Biotech, Inc. | 5 | $118 |
| Organon LLC | 10 | $93 |
| UCB, Inc. | 1 | $91 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
Products named: BOTOX, Zoryve, DUPIXENT, TALTZ, SKYRIZI, TREMFYA, Bimzelx, VTAMA.
Industry payments across TX — which companies pay providers there.
